Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Relapses do not matter in relation to long-term disability: yes.

Casserly C, Ebers GC.

Mult Scler. 2011 Dec;17(12):1412-4. doi: 10.1177/1352458511427514. No abstract available.

PMID:
22130597
2.

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.

Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, Ebers GC.

Brain. 1999 Oct;122 ( Pt 10):1941-50.

PMID:
10506095
3.

Relapses do not matter in relation to long-term disability: no (they do).

Lublin FD.

Mult Scler. 2011 Dec;17(12):1415-6. doi: 10.1177/1352458511427515. No abstract available.

PMID:
22130598
4.

Relapses do not matter in relation to long-term disability: commentary.

Hutchinson M.

Mult Scler. 2011 Dec;17(12):1417. doi: 10.1177/1352458511427512. No abstract available.

PMID:
22130599
5.

MRI lesion loads and disability relationships in MS: more similar than different?

Wolinsky JS.

Neurology. 2009 Nov 10;73(19):1524-5. doi: 10.1212/WNL.0b013e3181c2f091. Epub 2009 Oct 14. No abstract available.

PMID:
19828867
6.

The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.

Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC.

Brain. 2006 Mar;129(Pt 3):584-94. Epub 2006 Jan 9.

PMID:
16401620
7.

Natural history of multiple sclerosis: a unifying concept.

Confavreux C, Vukusic S.

Brain. 2006 Mar;129(Pt 3):606-16. Epub 2006 Jan 16.

PMID:
16415308
8.

A reassessment of the plateauing relationship between T2 lesion load and disability in MS.

Sormani MP, Rovaris M, Comi G, Filippi M.

Neurology. 2009 Nov 10;73(19):1538-42. doi: 10.1212/WNL.0b013e3181c06679. Epub 2009 Sep 30.

PMID:
19794123
9.

Relapses and progression of disability in multiple sclerosis.

Confavreux C, Vukusic S, Moreau T, Adeleine P.

N Engl J Med. 2000 Nov 16;343(20):1430-8.

11.

The effect of interferon-beta1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis.

Motamed MR, Najimi N, Fereshtehnejad SM.

Clin Neurol Neurosurg. 2007 May;109(4):344-9. Epub 2007 Feb 14.

PMID:
17300863
12.

[Clinical evaluation of follow-up and disease course].

Roullet E.

Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):1121-3. French.

PMID:
11787343
13.

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.

Kuhle J, Leppert D, Petzold A, Regeniter A, Schindler C, Mehling M, Anthony DC, Kappos L, Lindberg RL.

Neurology. 2011 Apr 5;76(14):1206-13. doi: 10.1212/WNL.0b013e31821432ff. Epub 2011 Feb 23.

PMID:
21346223
14.

Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis.

Petereit HF, Pukrop R, Fazekas F, Bamborschke SU, Röpele S, Kölmel HW, Merkelbach S, Japp G, Jongen PJ, Hartung HP, Hommes OR.

J Neurol Sci. 2003 Feb 15;206(2):209-14.

PMID:
12559513
15.

Lesley's story: a case report, and discussion of challenges faced in end-of-life care for progressive neurological disease.

Foley P, Hampton J, Hampton A, Hampton R, Oleksy D, Oliver D, Weller BJ.

Pract Neurol. 2012 Aug;12(4):244-8. doi: 10.1136/practneurol-2012-000263. Review. No abstract available.

PMID:
22869768
16.

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.

Sormani MP, Stubinski B, Cornelisse P, Rocak S, Li D, De Stefano N.

Mult Scler. 2011 May;17(5):541-9. doi: 10.1177/1352458510391837. Epub 2010 Dec 9.

PMID:
21148262
17.

[Immunologic therapy for secondary and primary progressive multiple sclerosis].

Ozawa K.

Nihon Rinsho. 2003 Aug;61(8):1449-54. Review. Japanese.

PMID:
12962037
18.

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis.

Vukusic S, Confavreux C.

J Neurol Sci. 2003 Feb 15;206(2):135-7. Review.

PMID:
12559500
19.

The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis.

Ebers GC, Koopman WJ, Hader W, Sadovnick AD, Kremenchutzky M, Mandalfino P, Wingerchuk DM, Baskerville J, Rice GP.

Brain. 2000 Mar;123 Pt 3:641-9.

PMID:
10686184
20.

TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS.

Killestein J, Kalkers NF, Meilof JF, Barkhof F, van Lier RA, Polman CH.

Neurology. 2001 Sep 25;57(6):1129-31.

PMID:
11571353

Supplemental Content

Support Center